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Abstract The function of phagocytic and antigen presenting
cells is of crucial importance to sustain immune competence
against infectious agents as well as malignancies. We here
describe a reproducible procedure for the quantification of
phagocytosis by leukocytes in whole blood. For this, a pH-
sensitive green-fluorescent protein- (GFP) like dye (Eos-FP)
is transfected into infectious microroganisms. After UV-
irradiation, the transfected bacteria emit green (≈5160 nm)
and red (≈581 nm) fluorescent light at 490 nm excitation.
Since the red fluorescent light is sensitive to acidic pH, the
phagocytosed bacteria stop emitting red fluorescent light as
soon as the phagosomes fuse with lysosomes. The green
fluorescence is maintained in the phagolysosome until
pathogen degradation is completed. Fluorescence emission
can be followed by flow cytometry with filter settings
documenting fluorescence 1 (FL 1, FITC) and fluorescence 2
(FL2,phycoerythrin,PE).Eos-FPtransfectedbacteriacanalso
be traced within phagocytes usingmicroscopicaltechniques.A
standardized assay has been developed which is suitable for
clinical studies by providing clinicians with syringes pre-filled
with fixed and appropriately UV-irradiated Eos-FP E. coli
(TruCulture™). After adding blood or body fluids to these
containers and starting the incubation at 37°C, phagocytosis
by granulocytes proceeds over time. Cultures can be termi-
nated at a given time by lysing red blood cells followed by
flowcytometry.ApilotstudydemonstratedthatEos-FPE.coli
phagocytosisanddigestionwasup-regulatedinthemajorityof
patients with either severe sepsis or septic shock as compared
to healthy donors (p<0.0001 after o/n incubation). Following
treatment with recombinant human granulocyte colony-
stimulating factor (rhG-CSF) in selected patients with sepsis,
phagolysosome fusion appeared to be accelerated.
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Introduction
Polymorphonuclear neutrophils (PMN) play a pivotal role
in the unspecific immune response (Smith 1994). One of
the first steps in the elimination of microorganisms is
phagocytosis by PMN. Patients with impaired neutrophil
function are at increased risk of developing sepsis that
progresses to septic shock and multiple organ failure (Martin
et al. 1989;( V i n c e n te ta l .1998) with its accompanied high
mortality rate (40% to 60%) (Casey et al. 1993; Friedman et
al. 1998). Diminished function of PMN, such as phagocytic
activity of granulocytes, may contribute to reduced elimina-
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DOI 10.1007/s12079-010-0112-0tion of microorganisms. As a result, infection can go on,
leading to severe sepsis or septic shock. The improved
diagnosis of neutrophil dysfunction in neonates is a highly
requested tool in modern medicine (Melvan et al. 2010).
Granulocyte colony-stimulating factor (G-CSF), a hema-
topoietic growthfactor, which isup-regulated during bacterial
infections (Omori et al. 1992), plays a central role in
functional recruitment and activation of mature and imma-
ture neutrophils (Kawakami et al. 1990; Weiss et al. 1999).
In order to maintain successful anti-infective defense,
endogenous production of G-CSF is indispensable for
reproduction and functional activation of neutrophils. Worse
outcome has been reported in patients with bacterial
infections and low endogenous serum concentrations of
G-CSF (Chen et al. 1995). Patients who recover from the
infection showed an immediate increase of endogenous
G-CSF serum concentrations and leukocyte counts, followed
by a decrease (Kragsbjerg et al. 1996; Tanaka et al. 1996).
The beneficial application of supplementation with myeloid
growth factors, GM-CSF and G-CSF, has been a matter of
discussion for many years (Carr et al. 2003).
Phagocytosis is a process to inactivate pathogens and to
sensitize the immune system for the generation of cytotoxic
cells and specific antibodies against antigen specific helper
T cells. A number of surface receptors are known to
regulate activation of the phagocyte and its function, i. e.
the uptake of antigens and intracellular degradation. These
are chemokine- and Fc gamma-receptors (CD16, CD32,
CD64), as well as intercellular adhesion molecule 1
(ICAM-1), integrins, CD11b, L-selectin, CD62-L and
complement receptors (Seely et al. 2003). In severe sepsis
associated with a high incidence of mortality (Casey et al.
1993; Friedman et al. 1998), a number of pathologies have
been reported to cause anergy and death by nosocomial
infections (Bone 1996). Amongst others, the Trojan horse
theory may be put forward, suggesting that pathogens
invade the organism and eventually are taken up and
spread by phagocytes without being efficiently degraded.
Therefore, pathogens may migrate to tissues sensitive for
infections and cause lesions. Cytokines and growth factors
play a major role in guiding the recruitment of neutrophil
effectors to the periphery as well as to sites of infections.
In this context, G-CSF has been demonstrated to play a
major role (Furze and Rankin 2008).
To address the question of neutrophil function in healthy
donors as compared to patients with sepsis and septic shock,
we set up a test which can be used to simultaneously study i)
pathogen phagocytosis and ii) the degradation of the
phagocytosed particle when entering the lysosomal compart-
ment. For this, E. coli bacteria were transfected with a pH-
sensitive dye, Eos-FP which had been cloned from a coral
Lobophyllia hemprichii (Wiedenmann et al. 2004). After
irradiating the transfected bacteria with UV-light of 400 nm,
peptide cleavage in Eos-FP occurs and the transfected
bacteria emit green as well as red fluorescent light upon
excitation with 490 nm (Wiedenmann et al. 2004). Interest-
ingly, the green fluorescence is quite stable whereas the red
fluorescence is pH sensitive. For assay standardization, the
UV-irradiated Eos-FP bacteria were fixed with paraformal-
dehyde, washed and the bacteria concentration was adjusted
to the phagocytic capacity of granulocytes from healthy
donors in 0.5 ml of whole blood. When whole blood was
mixed with Eos-FP bacteria, the pathogens were taken up
and eventually, phagosomes fused with lysosomes and the
acidic pH resulted in the loss of the red fluorescent light,
whereas the green fluorescent light emission was maintained
as long as protein degradation was incomplete. Healthy
donors were compared with sepsis patients. Individual sepsis
patients were also tested before and after treatment with rhG-
CSF (Neupogen®) (300 μg/24 h).
Methods
Eos-FP E. coli
A pH-sensitive green-fluorescent protein- (GFP) like dye
(Eos-FP), cloned from a coral Lobophyllia hemprichii was
transfected into E. coli K12. After growing the bacteria to a
cell density of 10
10 bacteria/ml, the fluorescent micro
organisms were irradiated with a UV light source of
400-nm to induce peptide cleavage of a majority of Eos-FP
molecules resulting in fluorescence emission from green
(520 nm) to red (580 nm) at 490 nm excitation (Wiedenmann
etal. 2004) (Patent 102006062398.3). The irradiated bacteria
were then fixed with 3.5% paraformaldehyde (electron
microscopical grade, www.emsdiasum.com) and washed in
sterile phosphate buffered saline.
Assay development
The amount of 1×10
8 fluorescent bacteria per 2 ml of
RPMI1640, 25 mM Hepes, 100U/ml sodium heparin were
filled into TruCulture™ containers (EDI-GmbH, Reutlingen,
Germany) designed to be filled with 0.5 ml of fresh
heparinized (50 IU/ml) peripheral blood. The containers were
stored at +4° for 1 week or at −20°C for several weeks in the
dark until used.
For assay-performance, Eos-FP-TruCultures were
thawed and adjusted to room temperature. Whole blood
was added to the first tube, which was placed on ice after
1 min following gentle mixing. For other time points, the
Eos-FP-TruCultures™ were mixed with 0.5 ml of whole
blood, gently mixed and placed into an incubator (37°C) in
an upright position. After 30 min, 60 min, 120 min and
following overnight (o/n) incubation, the TruCultures™
136 L. Schreiner et al.were removed from the incubator and phagocytosis was
terminated on ice. The supernatant was removed and
sedimented blood was subjected to 5 ml of lysing buffer
(BD-Biosciences) to remove red cells. Following 2 washes
with PBS, the cell suspension was ready to be analyzed by
flow cytometry. Non-specific adhesion of fluorescent
bacteria were tested by analyzing blood samples mixed
with Eos-FP bacteria for 1 min (Santos et al. 1995).
Fluorescence microscopy and flow cytometric analysis
(FACS)
White blood cell populations were gated into lympho-
cytes (R1), monocytes and macrophages (R2) and
neutrophils (R3) using forward and side scatter analysis
in a FACScalibur (BD Biosciences). Supplementary
Figure 1 shows, how granulocytes were gated by scatter
analysis. The gated granulocyte population was identi-
fied by surface staining of CD45 and CD14. A larger set
of monoclonal antibodies specifically binding to
granulocytes (CD16, CD33), monocytes/macrophages
(HLA-DR) and lymphocytes (CD2, CD19) was also used
(data not shown). In order to distinguish surface-bound
bacteria from those being engulfed by the phagocytes,
we compared flow cytometric results of samples treated
with and w/o methylene blue to quench the fluorescence
of extracellular E. coli. We also performed short-term
incubation of Eos-FP E. coli in whole blood (1 min)
according to Santos and colleagues (Santos et al. 1995)
Fluorescence of phagocytes with ingested bacteria was
determined by documentation of green (fluorescence 1
(FITC channel), FL1) and red fluorescence (fluorescence
2 (PE channel), FL2). Results were recorded as the
percentage of granulocytes emitting green plus red
fluorescence after a defined culture period and as mean
fluorescence intensity (MFI) related to the amount
of ingested fluorescent pathogens (MFI are calculated
by the following formula: percent positive cells ½   
mean channel fluorescence ½    percent positive cells in ½
the negative control   mean channel of the negative ½
control ). We also determined the ratio of green to red
fluorescence as a measure of phagosome-lysosome
fusion. For documentation of the results we used
CellQuest software (BD Biosciences).
Standard fluorescence microcopy with an upright
microscope (Zeiss) using with an excitation filter 450–
490 nm, FT510 and LP 520 nm, 63× oil immersion
objective was applied. A confocal laser scanning micro-
scope (Zeiss LSM501 meta, 63× objective) was used for
spectral light emission analysis and z-stack analysis
(0.5 μm/section, LSM 501 meta™ software (Zeiss.de)
for localization of intra- vs. extracellular bacteria. In
selected experiments cultured macrophages were applied
for improved spatial resolution in the cytoplasm. IBIDI™
μ-slides (Ibidi.de) were used throughout.
Patients
Seventeen patients with severe sepsis (n=5) and septic shock
(n=12) admitted at the Intensive Care Unit (ICU), Dept.
Anaesthesiology, University Hospital Ulm were included in
this pilot study (Table 1). Sepsis, was defined by the 1992
American College of Chest Physicians / Society of Critical
Care Medicine (ACCP/SCCM) consensus conference
definitions (American 1992). Severe sepsis was defined as
sepsis plus organ dysfunction. As recommended (Vincent et
al. 1998), in the present study, applying the 1992 sepsis
definitions, organ failure was regarded to be present if
patients had lactic acidosis or oliguria, or reached greater
than two points in one organ system (lung, coagulation,
liver, kidney) using the SOFA (Sepsis-related Organ
Failure Assessment) score. Septic shock was defined as
sepsis plus shock. Shock was defined as hypotension
despite adequate volume resuscitation, a systolic blood
pressure of ≤90 mmHg, or the need for vasopressors to
keep blood pressure greater than 90 mmHg. Stages of
sepsis and the SOFA score were monitored on a daily
basis to assess the severity of illness. In a pilot study
approved by the local ethics committee, aimed at the
evaluation of immune function in patients under intensive
care treatment, the function to ingest Eos-FP bacteria was
analyzed by comparing n= 1 7p a t i e n t sw i t hs e v e r es e p s i s
o rs e p t i cs h o c kw i t h2 8h e a l t h yd o n o r sw i t h o u tc u r r e n t
infection. Table 1 summarizes the patients’ characteristics.
Statistics
Comparisons among values for all groups were performed
with an analysis of variance (ANOVA). The phagocytosis
(uptake of fluorescent bacteria) and digestion (decline of red
fluorescence emission of ingested Eos-FP E. coli) bacteria in
healthy volunteers and in patients with severe sepsis were
compared by describing. The Mann-Whitney U-test was
applied to compare phagocytosis and digestion of Eos-FP E.
coli data between healthy volunteers and patients with sepsis.
A p-value of less than 0.05 was considered significant.
Results
Fluorescence emission of Eos-FP-transfected E. coli
by confocal laser scanning microscopy
Isolated granulocytes were with fixed and UV-irradiated
Eos-FP-transfected E. coli in medium containing 5%
human serum for different periods of time. Phagocytes
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15well µ-slides (Ibidi™). When using standard fluores-
cence microscopy and excitation with 450–490 nm fluo-
rescent light and a FT 510 nm and LP 520 nm filter
combination, non-digested Eos-FP bacteria appear in an
orange color and phagocytosed Eos-FP emitted only green
fluorescent light (Fig. 1). Confocal scanningmicroscopyand
spectral analysis of the emitted light was used to study the
fluorescence emission of isolated bacteria labeled as a region
of interest (ROI). According to the information given in
Fig. 1b, c, undigested Eos-FP E. coli emit green (515 nm)
and red (575 nm) fluorescent light (ROI2 and 3, Fig. b, c),
whereas Eos-FP bacteria that has entered the lysosomal
compartment lack red fluorescent light emission (ROI4,
Fig. 1b, c). The peak height of light emission is directly
related to fluorescence intensity. Following proteolytic
degradation ingested Eos-FP bacteria eventually completely
lose fluorescence (data not shown in Fig. 1).
Detection of phagocytosis of Eos-FP labeled E. coli
using flow cytometry
When testing whole blood samples of several individuals
at a time, flow cytometry is a suitable method to quantify
Eos-FP E. coli phagocytosis and subsequent degradation
in the lysosomal compartment. For this procedure, the
amount of bacteria has been adjusted to complete uptake
and digestion by polymorph nuclear cells in 0.5 ml of
whole blood (diluted in 2.0 ml of serum-free culture
medium) and a defined incubation time of less than 24 h.
Representative dot blots and gating strategies to identify
lymphocytes, granulocytes and lymphocytes are shown in
Fig. 2a.F i g u r e2b demonstrates a representative example
of whole blood flow cytometric analysis after various
incubation times. After one minute, the granulocyte
population lacks any fluorescence, indicating that there
was no non-specific adhesion of Eos-FP E. coli to the
granulocyte fraction. After 30 min, about 50% of the
granulocyte fraction emit green (FL 1) as well as red
(FL 2) fluorescent light due to phagocytosis of Eos-FP E.
coli. After 60 min and 120 min of incubation, the relative
amount of red fluorescence is gradually declining. After
o/n incubation, almost 100% of granulocytes lack red
fluorescence but green fluorescence remains. Almost all
granulocytes appear in the lower right quadrant of the dot
plot (Fig. 2b). The specificity of gating is demonstrated by
the distinct expression of the leukocyte common antigen
CD45 as well as CD14 (supplementary Figure 1A, B)
using FITC and phycoerythrin- (PE-) labeled monoclonal
antibodies. CD45 density is characteristically lower on
granulocytes as compared to eosinophiles and monocytes,
respectively. In selected experiments performed with
sepsis patients, the granulocytes’ expression of the
following myloid differentiation antigens has been per-
formed: CD11b (integrin), CD16 (FcR typeII), CD64
(FcRtypeI), CD62L, CD33 (myeloid antigen) as well as
Table 1 Patients characteristics
Main diagnosis Malignancy Surgery E NE SOFA Sex Age
Severesepsis Peritonitis A 0 0 2 m 26
Severesepsis Necrotizing fasceitis W 0 0 5 m 61
Septic shock* Paralytic ileus; peritonitis A 1 1 9 f 74
Septic shock* Ileus, peritonitis GIST A 0 1 7 m 76
Severesepsis Colon perforation A 0 0 3 f 45
Septic shock Anastomotic lesion A 1 1 5 m 74
Septic shock Generalized peritonitis A 0 0 2 f 45
Septic shock Anastomotic leakage Colon-CA A 0 1 7 f 45
Septic shock Ileus, pneumonia A 0 1 6 f 45
Septic shock Generalized peritonitis A 0 1 9 m 77
Septic shock Wound abscess Renal CA W 0 1 11 m 59
Septic shock Fournier gangrene W 0 1 7 m 57
septic shock Fasciitis W 1 1 14 m 52
Severesepsis* Anastomotic leakage Colon-CA A 0 0 7 f 64
Septic shock Bronchial stump insufficiency NSCLC L 0 1 5 f 58
Severe sepsis Osteomyelitis W 0 0 0 f 37
Septic shock Pneumonia NSCLC L 1 1 4 m 55
GIST, gastro intestinal stromal tumor, NSCLC non small cell lung cancer, A abdominal surgery, L lung surgery, W infected wound surgery, E
epinephrine, NE norepinephrine, *: patient died during stay on ICU
138 L. Schreiner et al.HLA-DR (data not shown, (Woehrle et al. 2008)). After a
series of healthy donors’ blood samples (n=28) had been
tested, fresh blood of 17 patients with severe sepsis or
septic shock was subjected to Eos-FP E. coli phagocytosis.
Phagocytosis of Eos-FP labeled E. coli in patients
with sepsis
As summarized in Fig. 3, the fluorescence emission of
granulocytes phagocytosing Eos-FP E. coli increases with
the time of incubation. It is more suitable to monitor the
stable green fluorescence emission, given as mean fluores-
cence intensity (MFI). There is higher phagocytic activity
in sepsis patients as compared with healthy donors. The
difference reaches significance after 120 min (p<0.05) and
after o/n incubation (p<0.001).
Phagosome-lysosome fusion kinetics of Eos-FP E. coli
in patients with sepsis
Figure 4 demonstrates that granulocytes of patients with
sepsis show a faster loss of red fluorescence emission
due to phagosome-lysosome fusion events. The red
fluorescence of Eos-FP is highly sensitive to acidic pH.
T h u st h ee a r l i e rt h ed e c l i n eo ft h er e df l u o r e s c e n c ei s
observed, the more efficient or the more rapid is the
phagosome-lysosome fusion process. This effect can be
quantified by calculating the ratio of the mean fluores-
cence intensity of the green fluorescence divided by the
mean fluorescence intensity of the red fluorescence. The
differences between healthy donors and patients with
sepsis were significant at all time points (p<0.001)
(Fig. 4).
Fig. 1 Fluorescence imaging of phagocytes after 3 h Eos-FP phagocy-
tosis. Standard immune fluorescence microscopy using excitation filter
450–490nm,FT510andLP520nm,63×oilimmersionmicroscopyand
Ibidi μ-slides. The distally located bacteria have just been phagocytozed
and emit green and red fluorescent light (appearing orange in color). The
phagocytosed bacteria entering the lysosomal compartment are partially
degraded and emit only green fluorescent light (a). Confocal scanning
microscopical image (Zeiss 510 Meta spectral analysis, 63× oil
immersion objective), and spectral analysis of individual regions of
interest (ROI) are labeled as colored crosses (region of interest, ROI2:
green, ROI3: blue, ROI4: yellow). The phagocytes’ nuclei appear dark
and are encircled by a dotted line. Bacteria appear turquoise in color (b).
Spectral analysis of ROI2 (green) reveals two peaks of emitted
fluorescent light at ≈515 nm and at ≈575–580 nm. ROI3 (blue)s h o w s
the same peaks of fluorescent light at 515 nm and 580 nm, however, the
580 nm peak is less intense. ROI4 (yellow) shows fluorescence
emission at 515 nm, only (c)
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coli in patients with sepsis treated with recombinant
human granulocyte colony-stimulating factor (rhG-CSF,
Neupogen®)
Patients who did not up-regulate their leukocytes
during sepsis (Weiss et al. 2003) were treated with
300 μg of recombinant human granulocyte-colony stimu-
lating factor G-CSF (Neupogen®) per 24 h. Eos-FP
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Fig. 3 Total fluorescence detected in granulocytes of healthy donors
and sepsis patients after different incubation times with Eos-FP
transfected bacteria. Green fluorescence emission (given as mean
fluorescence intensity (MFI on the y-axis) was detected in granulo-
cytes of healthy donors and sepsis patients after different times of
incubation with Eos-FP transfected bacteria (x-axis). Significant
differences between groups are indicated by an asterix* above the
scatter plots
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Fig. 2 Fluorescence of granulocytes gated from whole blood phagocy-
tosisassayswithEos-FPE.coli.Scatteranalysis(forwardscatter,FSC:x-
axis, and side scatter, SSC: y-axis) of Eos-FP E. coli whole blood culture
terminated after 1 min (control), 30 min, 60 min, 120 min and o/n (A).
Fluorescence1 (FL 1,green,x-axis); fluorescence2 (FL2,red,y-axis) of
granulocytes after 1 min, 30 min, 60 min, 120 min, and o/n of whole
blood with Eos-FP E. coli. (B) Percent positive granulocytes emitting
green plus red fluorescence are given in the upper right quadrant and
granulocytesemittinggreenfluorescenceonlyaregiveninthelowerright
quadrant
140 L. Schreiner et al.phagocytosis demonstrates that and digestion analysis was
performed before and after treatment. All our patients
suffered from bacterial sepsis when examined in our study,
their peripheral granulocyte population was often in-
creased and a significant proportion of them displayed an
immature phenotype. Exogenous growth factors may
improve immune function against infectious agents. We
investigated whether treatment rhG-CSF (300 μg infused
in 24 h) would result in improved phagocytosis and
lysosomal degradation of Eos-FP E. coli. Figure 5 demon-
strates that G-CSF up-regulated phagocytosis in sepsis
patients. In 4 out of 5 patients’ samples, o/n incubation
resulted in less fluorescence emission after G-CSF treatment
as compared to pre-treatment values. These results indicate
that G-CSF also stimulated the degradation of phagocytosed
bacteria including the Eoos-FP dye (Fig. 5a). The
phagosome-lysosome function indicated by the loss of the
pH-sensitive red fluorescent light emission was also up-
regulated by G-CSF. There was one exception after o/n
incubation, when post G-CSF isolates had a higher green/red
ratio as compared to the pre-treatment value (Fig. 5b). In this
small patient population, there was no correlation with death
(red symbols) or survival of patients during their stay on
intensive care (ICU).
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Fig. 4 Phagosome-lysosome fusion after Eos-FP E. coli phagocytosis
of sepsis patients as compared to healthy donors. Ratios of green to
red fluorescence (y-axis) indicate phagosome-lysosome fusion and
acidic pH after Eos-FP E. coli phagocytosis. The medians of all
incubation time points (x-axis) analyzed are different between sepsis
patients and healthy donors. Significant differences between groups
are indicated by an asterix* above the scatter plots
Fig. 5 Phagocytosis and phagosome-lysosome fusion in sepsis
patients before and after treatment with rhG-CSF (a). Phagocytosis
is quantified by MFI (y-axis) after different time points (x-axis). MFI
are in part higher when tested after G-CSF treatment up to 120 min.
However, after o/n incubation all but one post-GSF specimen display
less fluorescence than pre-G-CSF specimen (a). Phagosome-lysosome
fusion is upregulated in all but one patient’s granulocytes post G-CSF
treatment up to 120 min. Following o/n incubation, one isolate shows
a delay in phagosome-lysosome fusion events (b). Red symbols are
from patients who died during their stay on ICU
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The present investigation demonstrates that fluorescent
dyes may be applied to simultaneously quantify phagocy-
tosis and phagosome-lysosome fusion events in whole
blood isolates. The present study extends currently avail-
able phagocytosis assays using FITC-labeled bacteria
(Burow and Valet 1987; Rothe et al. 1992; Rothe and Valet
1988; Gille et al. 2009). These experimental set-ups are also
similar to a previous study, when GFP transfected E. coli
were applied (Bicker et al. 2008). In our procedure, we
used fixed E. coli transfected with a novel GFP-like protein
named Eos-FP. The irradiation of Eos-FP with UV light
genereates a partially degraded molecule with pH-sensitive
red fluorescent emission properties (Wiedenmann et al.
2004; Wiedenmann and Nienhaus 2006). Therefore, Eos-FP
transfected E. coli are suitable i) to quantify phagocytic
granulocytes (percent fluorescent granulocytes), ii) to
quantify the amount of ingested bacteria (MFI, green
fluorescence), and iii) to determine phagolysosome fusion
(green-to-red ratio).
To establish this phagocytosis and digestion assay, we
applied E. coli K12 for convenience but other pathogenic
bacteria of interest can similarly used. Using confocal
scanning microscopy and spectral analysis, individual
bacteria can be located within or outside of the phagocyte.
CLSM combined with computed imaging analysis enables
us to observe these structures three-dimensionally in
routinely processed light microscopic specimens (White et
al. 1987). Confocal imaging reduces interference from out-
of-focus structures and optical slices of 0.25 μm were
applied for image analysis. Intracellular bacteria show
various grades of reduced red fluorescent light but non-
phagocytozed bacteria emitted the same intensity of green
(518 nm) as well as red (581 nm) fluorescence upon
excitation at 490 nm (Fig. 1). When using standard immune
fluorescence, the non-digested bacteria appear orange in
color and locate to the outer rim of the phagocyte. The
fluorescent bacteria in the inner part of the phagocyte are
only green fluorescent and many are also structurally
degraded (Fig. 1a).
The unique dual emission wavelengths of Eos-FP make
this dye suitable to be used by flow cytometry for
quantification. The green fluorescence intensity (FL 1)
correlates with the amount of phagocytozed pathogens;
beyond that, the selective green to red fluorescence (FL 1 to
FL 2 ratio) indicates phagosome-lysosome fusion. A
quantitative loss of green fluorescence indicates proteolytic
degradation of the ingested bacteria including the Eos-FP
dye. According to the standards established here, we
observed only in G-CSF-treated patients that full degrada-
tion of the phagocytosed bacteria occurred at the latest time
point of o/n incubation (Fig. 5). The cell populations present
in cell mixtures can be either identified by scatter analysis
or stained by surface markers using fluorescence-labeled
antibodies labeled which do not interfere with the emission
spectrum of Eos-FP. The aim of the current study was the
investigation of granulocyte-specific phagocytosis and
digestion. Gating was done by scatter analysis and
confirmation of CD45 and CD14 expression density
(Canonico et al. 2004) in every blood sample tested by
Eos-FP phagocytosis. In initial experiments, gating strate-
gies were additionally evaluated by staining for other
granulocyte-specific surface antigens such as CD13,
CD15, CD16, CD64, CD32 (data not shown). Our Eos-FP
phagocytosis and digestion assay uses fixed and fully
dispersed bacteria which can be either stored at 4°C in the
dark or in a frozen state using pre-filled syringes designed
as TruCulture™. Thus the assay is unique in being able to
perform patients’ studies in different centers and to fuse the
analysis into larger cohort studies. The effects of various
medications on the function of phagocytes can be moni-
tored as exemplified by rhG-CSF application in the present
study. In the future, the Eos-FP construct may be further
valid for testing the effect mediated by other bacterial
products which may or may not influence the formation of
the phagolysosome (Hines et al. 1999; Gorvel and Moreno
2002; Makino et al. 2007). Importantly, the intracellular
processing of pathogens is related to the activation of the
immune system as much as the inflammatory response as
such. Sustained immunity against a pathogen is accomplished
by uptake, degradation, and processing and antigen presenta-
tion, leading to the sensitization of T- and B-cell immunity.
The generation of protein-derived peptides preferentially
occurs in professional antigen presenting cells and the
machinery of proteasome-guided degradation. However,
DNA-vaccines have proven that our understanding of
intracellulartraffickingaswellasthechemistryofdegradation
is still incomplete. A more detailed analysis of GFP-derived
proteins which can be used as tags to follow trafficking
processes in an antigen presenting cell may help to address
open questions (Nienhaus and Wiedenmann 2009).
Results presented here confirm the previous notion that
granulocytes of patients with sepsis have an increased
functional capacity (Rothe et al. 1992) and are also less
apoptotic (Weiss et al. 2003; Marshall et al. 2007). The
inhibition of phagocytosis is a result of a number of growth
factors produced in the inflammatory environment. Figure 5
summarizes that not all patients respond with increased
phagocytosis, but almost all patients’ granulocytes showed
up-regulated phagolysosome fusion after rhG-CSF infusion.
In the present study, the usefulness of Eos-FP E. coli to
study processes which occur in the lysosomal compartment
in human cells has been demonstrated. None of our patients
suffering from either severe sepsis or septic shock had a
profound deficiency to ingest and degrade Eos-FP E. coli.
142 L. Schreiner et al.On the contrary, the majority of patients were far more
active in both, the amount of pathogen uptake (Fig. 3)a s
well as its degradation as demonstrated by phagolysosome
fusion, corresponding to a higher and faster increase of the
green-to-red ratio (Fig. 4). Altogether, the current results
demonstrate that a deficiency of granulocytes to ingest and
degrade bacteria is not responsible for dissemination of
pathogens through the body that contribute to deterioration
during sepsis. Moreover, the present study shows that the
here applied whole blood Eos-FP E. coli phagocytosis is
valid to substantiate the effects of growth factor treatment
in septic patients. Along these lines we found that in vivo
application of rhG-CSF stimulated not only phagocytosis
but also enhanced the velocity of the phagosome-lysosome
fusion process accompanied by degradation of the ingested
pathogen in 3 of 5 sepsis patients.
These results may contribute in clarifying the current
discussion of the Trojan horse hypothesis to explain
pathogen transmission throughout the body of a sepsis
patient (Kim 2008). However, live bacteria have to be
tested in the Eos-FP E. coli phagocytosis assay as well. As
demonstrated before, the uptake and degradation of living
pathogens is intrinsically different from that of dead
organisms and the ratio of pathogens to phagocytes
influences the fate of the neutrophils to either enter
apoptosis or die by necrosis (Matsuda et al. 1999). All
these questions can be addressed by application-dependent
modifications of the currently described assay protocol.
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